Global Assisted Reproductive Technology (ART) Market – In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022

November 2017 | 77 pages | ID: G051EA55EB3EN
Rockville Research

Abstracts

The problem of infertility has aggravated globally with rise in advanced maternal age and various other factors. “Global Assisted Reproductive Technology (ART) Market – In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022” provides an in-depth analysis of global Assisted Reproductive Technology (ART) market overall as well as major technologies such as In Vitro Fertilization, Artificial Insemination and Third-Party Assisted ART (Sperm donation, Egg donation, Embryo donation and Surrogates). Market outlook for overall Assisted Reproductive Technology (ART) market as well as aforementioned sub-segments has been provided for the period 2017-22.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global assisted reproductive technology market. The report has been segmented as following:-

Market Segmentation

• In Vitro Fertilization
• Artificial Insemination
• Third-Party Assisted ART

Geographical Coverage

• Global
• Americas
• Asia Pacific
• Europe, Middle East & Africa

Companies Coverage

• Merck & Co., Inc.
• CooperSurgical, Inc.
• Irvine Scientific Sales Company, Inc.
• Vitrolife AB
• Hamilton Thorne, Inc.,

Contents

1. EXECUTIVE SUMMARY

2. RESEARCH METHODOLOGY

3. ASSISTED REPRODUCTIVE TECHNOLOGY: INTRODUCTION

3.1 Infertility
  3.1.1 Causes of Infertility
  3.1.2 Infertility Treatments
3.2 Assisted Reproductive Technology (ART)
  3.2.1 IVF
  3.2.2 Assisted Insemination
  3.2.3 Third Party Assisted ART
  3.2.4 Assisted Reproductive Treatment (ART) Procedure

4. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS

4.1 Market Sizing
4.2 Market Share Analysis
  4.2.1 Market Share by Technology
  4.2.2 Market Share by Procedure
  4.2.3 Market Share by Region

5. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET SEGMENTATION

5.1 In Vitro Fertilization
  5.1.1 Overview
  5.1.2 IVF Procedure
  5.1.3 Market Sizing (Actual & Forecasted)
  5.1.4 Market Share by End-User
  5.1.5 Market Penetration by Nations
5.2 Artificial Insemination Market
  5.2.1 Overview
  5.2.2 Artificial Insemination Procedure
  5.2.3 Market Sizing (Actual & Forecasted)
  5.2.4 Market Share by Procedure
  5.2.5 Market Share by Region
5.3 Third-party assisted ART
  5.3.1 Overview

6. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) REGIONAL ANALYSIS

6.1 Americas
  6.1.1 Market Sizing (Actual & Forecasted)
  6.1.2 The US
6.2 Asia Pacific
  6.2.1 Market Sizing (Actual & Forecasted)
6.3 Europe Middle East & Africa (EMEA)
  6.3.1 Market Sizing (Actual & Forecasted)

7. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET DYNAMICS

7.1 Industry Trends & Development
  7.1.1 Strategic Alliances
  7.1.2 Technological Advancement
7.2 Growth Drivers
  7.2.1 Prevalence of Infertility
  7.2.2 Advanced Maternal Age
  7.2.3 High Obesity Rates
  7.2.4 Rising Level of Tobacco & Alcohol Consumption
  7.2.5 Low Awareness of Fertility Problems
  7.2.6 Favorable Reimbursements
7.3 Challenges
  7.3.1 Stringent Regulations
  7.3.2 High Treatment Cost

8. COMPETITIVE LANDSCAPE

9. COMPANY PROFILES

9.1 Merck & Co., Inc.
9.2 CooperSurgical, Inc.
9.3 Irvine Scientific Sales Company, Inc.
9.4 Vitrolife AB
9.5 Hamilton Thorne, Inc.